For example, rutaecarpine significantly decreased NF-κB protein levels in liver tissues and plasma inflammatory cytokines levels to ameliorate pathological changes in the liver, and blocked NF-κB p50/p65 in human colorectal cancer (Nie et al., 2016; Sui et al., 2016). This evidence concerns the gene NFKB1 and colorectal cancer.